Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 407

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial

Lee, Seung-Whan, Lee, Pil Hyung, Ahn, Jung-Min, Park, Duk-Woo, Yun, Sung-Cheol, Han, Seungbong, Kang, Heejun, Kang, Soo-Jin, Kim, Young-Hak, Lee, Cheol Whan, Park, Seong-Wook, Hur, Seung Ho, Rha, Seung-Woon, Her, Sung-Ho, Choi, Si Wan, Lee, Bong-Ki, Lee, Nae-Hee, Lee, Jong-Young, Cheong, Sang-Sig, Kim, Moo Hyun, Ahn, Young-Keun, Lim, Sang Wook, Lee, Sang-Gon, Hiremath, Shirish, Santoso, Teguh, Udayachalerm, Wasan, Cheng, Jun Jack, Cohen, David J., Muramatsu, Toshiya, Tsuchikane, Etsuo, Asakura, Yasushi, Park, Seung-Jung · 2019 · Circulation

Abstract

Background: Procedural results for percutaneous coronary intervention (PCI) in coronary vessels with chronic total occlusion (CTO) have improved in recent years, and PCI strategies have moved toward more complete revascularization with more liberal use of CTO-PCI. However, evidence evaluating CTO-PCI is limited to observational studies and small clinical trials. Methods: In this open-label, multicenter, randomized, noninferiority trial, PCI-eligible patients were assigned to receive either 1 of 2 strategies: PCI or no PCI for the qualifying de novo CTO lesion with the option for PCI of obstructive non-CTO lesions at the discretion of the operator. The primary end point was a composite of death, myocardial infarction, stroke, or any revascularization. Health-related quality of life was assessed at baseline and at 1, 6, 12, 24, and 36 months. Because of slow recruitment, the trial was stopped before completion of the 1284 planned enrollments. Results: Between March 2010 and September 2016, 834 patients were randomly assigned to the CTO-PCI (n=417) or no CTO-PCI (n=398) strategy. Among the patients assigned to the no CTO-PCI strategy, 78 (19.6%) crossed over to receive staged CTO-PCI within 3 days of randomization. The overall CTO-PCI success rate was 90.6%. Serious nonfatal complications associated with CTO-PCI occurred in 3 patients (1 stroke, 1 cardiac tamponade, and 1 patient with recurrent episodes of ventricular tachyarrhythmia induced by intracoronary thrombus). Approximately half of the patients in each group underwent PCI for an average of 1.3 non-CTO lesions, resulting in a comparable residual SYNTAX score (Synergy Between PCI With TAXUS and Cardiac Surgery; 3.7±5.4 versus 4.0±5.9, P =0.42) confined to non-CTO vessels. During a median follow-up of 4.0 years (interquartile range, 2.4 to 5.1 years), there was no significant difference between the CTO-PCI and the no CTO-PCI strategies in the incidence of the primary end point (22.3% versus 22.4%, hazard ratio, 1.03; 95% CI, 0.77 to 1.37; P =0.86). Both CTO-PCI and no CTO-PCI strategy were associated with significant improvements but without between-group differences in disease-specific health status that was sustained through 36 months. Conclusions: CTO-PCI was feasible with high success rates. There was no difference in the incidence of major adverse cardiovascular events with CTO-PCI versus no CTO-PCI, but the study was limited by low power for clinical end points and high crossover rates between groups. Clinical Trial Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT01078051.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.118.031313

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 21 references

Cited by

See all 407

Metadata

Authors
Lee, S.-W., Lee, P. H., Ahn, J.-M., Park, D.-W., Yun, S.-C., Han, S., Kang, H., Kang, S.-J., Kim, Y.-H., Lee, C. W., Park, S.-W., Hur, S. H., Rha, S.-W., Her, S.-H., Choi, S. W., Lee, B.-K., Lee, N.-H., Lee, J.-Y., Cheong, S.-S., Kim, M. H., Ahn, Y.-K., Lim, S. W., Lee, S.-G., Hiremath, S., Santoso, T., Udayachalerm, W., Cheng, J. J., Cohen, D. J., Muramatsu, T., Tsuchikane, E., Asakura, Y., & Park, S.-J.
Venue
Circulation
Published
2019-04-02
Volume
139
Issue
14
Pages
1674-1683
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2916496138
Cited by
407
References
21
FWCI
41.91
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial. https://app.cochat.ai/papers/10.1161/circulationaha.118.031313
The paper
Lee, S.-W., Lee, P. H., Ahn, J.-M., Park, D.-W., Yun, S.-C., Han, S., Kang, H., Kang, S.-J., Kim, Y.-H., Lee, C. W., Park, S.-W., Hur, S. H., Rha, S.-W., Her, S.-H., Choi, S. W., Lee, B.-K., Lee, N.-H., Lee, J.-Y., Cheong, S.-S., . . . Park, S.-J. (2019). Randomized Trial Evaluating Percutaneous Coronary Intervention for the Treatment of Chronic Total Occlusion: The DECISION-CTO Trial. Circulation. https://doi.org/10.1161/circulationaha.118.031313

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.